MnO2-shelled Doxorubicin/Curcumin nanoformulation for enhanced colorectal cancer chemo-immunotherapy-Reference-Cited by-同舟云学术

MnO2-shelled Doxorubicin/Curcumin nanoformulation for enhanced colorectal cancer chemo-immunotherapy

Published:2022-07 Issue: Volume:617 Page:315-325
ISSN:0021-9797
Container-title:Journal of Colloid and Interface Science
language:en
Short-container-title:Journal of Colloid and Interface Science

Author:

Liu Jie,Li Li,Zhang Bing,Xu Zhi Ping

Funder

Australian Research Council

University of Queensland

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Surfaces, Coatings and Films,Biomaterials,Electronic, Optical and Magnetic Materials

Reference64 articles.

1. Emerging protein targets for metal-based pharmaceutical agents: An update;de Almeida;Coord. Chem. Rev.,2013

2. Metalloproteomics for Unveiling the Mechanism of Action of Metallodrugs;Wang;Inorg. Chem.,2019

3. Emerging Metallopharmaceuticals for the Treatment of Cancer;Johnson;Trends Chem.,2021

4. Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer;Loupakis;N. Engl. J. Med.,2014

5. Comparison the Incidence and Severity of Side Effects Profile Of FOLFOX and DCF Regimens in Gastric Cancer Patients;Salehifar;Iran. J. Pharm. Res.,2019

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A biocompatible drug controlled release system based on β-cyclodextrin crosslinked magnetic lactose/ZIF-8 metal-organic frameworks for cancer treatment;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-11

2. Self-Delivery Nanobooster to Enhance Immunogenic Cell Death for Cancer Chemoimmunotherapy;ACS Applied Materials & Interfaces;2024-06-25

3. Iron-Based Metal-Organic Frameworks as Multiple Cascade Synergistic Therapeutic Effect Nano-Drug Delivery Systems for Effective Tumor Elimination;Pharmaceuticals;2024-06-20

4. Advances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy;Small;2024-05-21

5. Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved;Antioxidants;2024-04-18